Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
ADENE-ASSOCIATED VIRAL VECTOR DELIVERY OF A MICRO-DYSTROPHIN FRAGMENT TO TREAT MUSCULAR DYSTROPHY
UndeterminedMA47800A
Owner:THE UNIVERSITY OF NEWCASTLE +1
BIOMATERIALS BASED ON SULFATED GLYCOSAMINOGLYCANES USED AS PROTEOGLYCAN MIMETICS
UndeterminedMA46426A
Owner:GLYCOLOGIX LLC
INTEROSSE COUPLER
UndeterminedMA55378A
Owner:NEW YORK SOC FOR THE RUPTURED & CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY
A device for aligning box-shaped items of various sizes onto a conveyor belt, including a printing station, a reading station, and a labeling station.
UndeterminedMA50789A
Owner:SICPA HOLDING SA
PHARMACEUTICAL COMPOSITIONS INCLUDING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE
Owner:ASTEX THERAPEUTICS LTD
METHOD FOR PRODUCING A CONTROLLED MIXTURE OF AT LEAST TWO DIFFERENT ANTIBODIES
UndeterminedMA52945A
Owner:GENMAB AS
IMPROVEMENT OF NEURAL DIFFERENTIATION OF VENTRAL MENSCEPHALUS NEURAL PROGENERATION CELLS
UndeterminedMA71320A
Owner:NOVO NORDISK AS
POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
UndeterminedMA46899A
Owner:VANDERBILT UNIV
ACTIVE AGENT INTENDED FOR USE IN REGULATING HAIR GROWTH
UndeterminedMA53469A
Owner:CUTANEON SKIN & HAIR INNOVATIONS GMBH
Non-antagonistic antibodies directed against the alpha chain of the extracellular domain of the IL-7 receptor and their use in cancer treatment
InactiveMA43767Aimproving clinical statusregain health
Owner:OSE IMMUNOTHERAPEUTICS SA
ANTI-ROLL DEVICE WITH ACTION MEANS CONTROLLED BY A HYDRAULIC CONTROL CIRCUIT, FOR A TRAIN OF MOTOR VEHICLES
UndeterminedMA50236A
Owner:BWI FRANCE S A S U +1
NEW CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL[(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)- 1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTATE
UndeterminedMA46513A
Owner:GILEAD SCIENCES INC
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS
UndeterminedMA47331A
Owner:MAGENTA THERAPEUTICS INC
COMPOUNDS FOR THE TREATMENT OF CANCER INDUCED BY AN ONCOVIRUS AND THEIR METHODS OF USE
UndeterminedMA55595A
Owner:CELLESTIA BIOTECH AG
COMBINATION TREATMENT WITH ANTIBODY-DRUG CONJUGATES AND PARP INHIBITORS
UndeterminedMA46779A
Owner:HEALTH RESEARCH INC +1
Growth Factor Variants of Modified Fibroblasts as Receptor Antagonists
UndeterminedMA53872A
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
SHEAR CORE ASSEMBLY INTERCONNECTED WITH COMPONENTS DESIGNED BY ADDITIVE MANUFACTURING
UndeterminedMA52660A
Owner:GENERAL ELECTRIC CO
MONITORING DEVICE FOR MONITORING A PHYSIOLOGICAL PARAMETER AND ASSOCIATED PROCESSES
UndeterminedMA51824A
Owner:BIOSENCY
PROCESS FOR PRODUCING KRAFT PULP FROM MIXTURES OF HARDWOOD AND SOFTWOOD, KRAFT PULP OBTAINED BY THE PROCESS AND PAPER PRODUCTS PRODUCED FROM THIS PULP
ActiveMA71427A
Owner:RAIZ - INSTITUTO DE INVESTIGAÇÃO DA FLORESTA EPAPEL
Anti-TNF antibodies, compositions and methods for the treatment of active psoriatic arthritis
UndeterminedMA47362A
Owner:JANSSEN BIOTECH INC
ANTI-TNF ANTIBODIES AND METHODS FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
UndeterminedMA54750A
Owner:JANSSEN BIOTECH INC
ASSEMBLIES AND METHODS FOR PRODUCING OPTICALLY EFFECTIVE COATINGS COMPRISING Oriented, NON-SPHERICALLY FLATTENED, ORIENTED MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES
ActiveMA50023A
Owner:SICPA HOLDING SA
PYRANNE DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS
UndeterminedMA55983A
Owner:ORION CORP(FI)
1,3-THIAZOL-2-YL SUBSTITUTION BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION
UndeterminedMA52616A
Owner:BAYER AG +1
MOTOR VEHICLE INTERIOR INCLUDING AN AIR DUCT FIXING SYSTEM IN A VENTILATION SYSTEM
InactiveMA53476A
Owner:PSA AUTOMOBILES SA
Thermosetting powder coating with non-stick properties, respective manufacturing and application processes, and corresponding coating
UndeterminedMA45605A
Owner:CIN IND COATINGS SA
OPHTHALMIC NUTRACEUTIC COMPOSITION FOR THE TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT
ActiveMA54511A
Owner:LABORATOIRES THEA SAS
LAMINATED GLAZING AND THE MANUFACTURING PROCESS FOR LAMINATED GLAZING
UndeterminedMA46602A
Owner:SAINT GOBAIN VITRAGE SA
CDPK1 INHIBITORS, COMPOSITIONS AND ASSOCIATED PROCESSES
UndeterminedMA53672A
Owner:VYERA PHARMACEUTICALS LLC +1
FORMULATIONS DE DERIVES DE PHOSPHORAMIDATE DE COMPOSES DE NUCLEOSIDE
UndeterminedMA44117A
Owner:NUCANA PLC
Compositions and methods for expressing multiple biologically active polypeptides from a single vector for the treatment of cardiac conditions and other pathologies
UndeterminedMA43404A
Owner:PRECIGEN INC
PROCESS FOR THE PRODUCTION OF SUBSTITUTED 2-[2-(PHENYL)ETHYLAMINO]ALKANEAMIDE DERIVATIVES
UndeterminedMA55714A
Owner:NEWRON PHARMACEUTICALS SPA
METHOD FOR IDENTIFYING A SUBSET INCLUDING A MUTATING ORGANISM
UndeterminedMA52594A
Owner:CARLSBERG BREWERIES AS
DEVICE FOR POSITIONING ON AN ELECTRICAL CONDUCTOR A MEANS OF IMPLEMENTING A GROUNDING SYSTEM FOR THAT ELECTRICAL CONDUCTOR
UndeterminedMA52849A
Owner:FAMECA
Hsp90-targeted inflammation and infection imaging and therapy
UndeterminedMA40535A
Owner:MEMORIAL SLOAN KETTERING CANCER CENT
Phosphatidylinositol-3-kinase Nucleic Acids and Their Uses
UndeterminedMA45471A
Owner:AVIDITY BIOSCI INC
METHOD AND SYSTEM INTENDED FOR DATA SECURITY IN INDEPENDENT COMPUTER SYSTEMS AND DIGITAL NETWORKS
UndeterminedMA49571A
Owner:ZAMNA TECH LTD
GAME RENDERING METHOD, AS WELL AS METHOD, APPARATUS AND DEVICE FOR GENERATING A GAME RESOURCE FILE
UndeterminedMA49644A
Owner:TENCENT TECHNOLOGY (SHENZHEN) CO LTD
OXADIAZOLOPYRIDINE DERIVATIVES USED AS GHRELIN O-ACYL TRANSFERASE INHIBITORS (GOAT)
Owner:BOEHRINGER INGELHEIM INT GMBH
GLAZING WITH PROFILE SEAL AND FURNITURE AND GLAZING MANUFACTURING METHOD
UndeterminedMA45273A
Owner:SAINT GOBAIN VITRAGE SA
METHOD FOR COOLING A BUILDING, AND EVAPORATIVE COOLING APPARATUS
UndeterminedMA50519A
Owner:WEEBER ISTVAN
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING TO PSMA AND CD3 IN COMBINATION WITH 4-1BB CO-STIMULATION
UndeterminedMA56515A
Owner:REGENERON PHARMACEUTICALS INC
PYRIDONE DERIVATIVES USED AS INHIBITORS OF REARRANGED KINASE DURING TRANSFECTION (RET)
UndeterminedMA40581A
Owner:GLAXOSMITHKLINE INTPROP DEV LTD
Composites containing fiberglass with a retained fiberglass length, improved impact resistance, and enhanced tensile properties
UndeterminedMA44628A
Owner:PPG INDUSTRIES OHIO INC
ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAK AND JAK INHIBITORS
UndeterminedMA47495A
Owner:GALAPAGOS NV
DEVELOPMENT OF HDAC3 CATALYTIC INHIBITORS AND THEIR USES
UndeterminedMA56213A
Owner:DANA FARBER CANCER INSTITUTE INC
PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-BST-1 ANTIBODY AND A CYTIDINE ANALOGUE
UndeterminedMA49627A
Owner:BERLIN CHEMIE AG
METHOD AND DEVICE FOR PRODUCING SULFURIC ACID FROM CONTAMINATED SULFURIC ACID MEDIA
UndeterminedMA52554A
Owner:P & P IND AG
BELUMOSUDIL METABOLITES AND THEIR USES IN THE TREATMENT OF CHRONIC GRAFTING VERSUS HOST DISEASE
UndeterminedMA71429A
Owner:KADMON CORP LLC
METHOD FOR PRODUCING A STARTING FORMULATION FOR A DERMATOLOGICAL LIGHTPROTECTION PREPARATION AND FOR PRODUCING A DERMATOLOGICAL LIGHTPROTECTION PREPARATION
UndeterminedMA52213A
Owner:ULTRASUN AG
AGRICULTURAL COMPOSITIONS AND ASSOCIATED PROCESSES
UndeterminedMA53391A
Owner:FLAGSHIP PIONEERING INNOVATIONS V INC
NEW HIGHLY ACTIVE AMINO-THIAZOLE SUBSTITUTION INDOLE-2-CARBOXAMIDES ACTING AGAINST HEPATITIS B VIRUS (HBV)
UndeterminedMA50524A
Owner:AICURIS GMBH & CO KG
COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES AND VERY LONG CHAIN FATTY ACID (VLCFA) INHIBITORS HERBICIDES
UndeterminedMA54172A
Owner:CORTEVA AGRISCIENCE LLC
ORGAN ORGANID AND ASSOCIATED PRODUCTION PROCESS
UndeterminedMA50831A
Owner:NAT UNIV CORP TOKYO MEDICAL & DENTAL UNIV
USE OF A CYCLIC TRIPEPTIDE TO IMPROVE CELLULAR ENERGY METABOLISM
ActiveMA42928A
Owner:CENT NAT DE LA RECH SCI (C N R S) +3
METHOD FOR CONTROLLING A TRAIN IN A TRAIN PROTECTION SYSTEM, TRAIN PROTECTION SYSTEM
UndeterminedMA52477A
Owner:THALES MANAGEMENT & SERVICES DEUTSCHLAND GMBH
CONTACT LENS MOLD WITH A RIM EDGE OR NOT ROTARILY SYMMETRICAL
UndeterminedMA54727A
Owner:JOHNSON & JOHNSON VISION CARE INC
PROCESS FOR PRODUCING E. COLI O-ANTIGEN POLYSACCHARIDE BIOCONJUGATES, THEIR COMPOSITIONS AND METHODS OF USE
Owner:JANSSEN PHARMACEUTICALS INC +1
MULTI-PLY SANITARY PAPER PRODUCT AND PROCESS THEREIN
UndeterminedMA47752A
Owner:ESSITY HYGIENE & HEALTH AB
METHODS AND SYSTEMS FOR MANUFACTURING PHOSPHORUS PENTOXIDE WITH IMPROVED COMPRESSION STRENGTH OF AGGLOMERATE
ActiveMA40762A
Owner:NOVAPHOS INC
APJ Receptor Agonist Triazoles
Owner:AMGEN INC
PHARMACEUTICAL COMBINATION AND ITS USE FOR THE TREATMENT OF SYNUCLEINOPATHIES
UndeterminedMA52457A
Owner:CHASE THERAPEUTICS CORP
CO-CRYSTALS, SALTS AND SOLID FORMS OF TENOFOVIR ALAFENAMIDE
UndeterminedMA46677A
Owner:GILEAD SCIENCES INC
TRIAMTERENE OR NOLATREXED INTENDED FOR USE IN THE TREATMENT OF PHENYLCETONURI
UndeterminedMA54936A
Owner:SOM INNOVATION BIOTECH SA
RING TOPOLOGY NETWORK ROBOTIC SURGICAL SYSTEM AND ITS METHOD OF USE
UndeterminedMA50184A
Owner:VERB SURGICAL INC
Anti-FLT-1 antibodies used in the treatment of bronchopulmonary dysplasia
UndeterminedMA41908A
Owner:SHIRE HUMAN GENETIC THERAPIES INC +1
Fractionated dosage of a phospholipid ether analogue for cancer treatment
UndeterminedMA52250A
Owner:CELLECTAR BIOSCIENCES INC
Human antibodies that bind to the RET and their methods of use
UndeterminedMA55615A
Owner:REGENERON PHARMACEUTICALS INC
NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
Owner:IMMATICS BIOTECHNOLOGIES GMBH
SYSTEMS AND METHODS FOR AN ELECTRODE INTENDED FOR AN ELECTRIC PULSE WEAPON
UndeterminedMA51160A
Owner:AXON ENTERPRISE INC
Sterilization apparatus for sterilizing absorbent sanitary products after use
UndeterminedMA47406A
Owner:FATER
INDANE DERIVATIVES INTENDED FOR USE IN THE TREATMENT OF BACTERIAL INFECTION
UndeterminedMA53707A
Owner:ANTABIO SAS
METHODS FOR PREDICTING THE USEFULNESS OF DISEASE-SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY
UndeterminedMA49246A
Owner:BIONTECH RNA PHARM GMBH
A THERMAL ENGINE CONFIGURED TO PERFORM THERMAL CYCLES AND A METHOD FOR PERFORMING THERMAL CYCLES BY MEANS OF SUCH A THERMAL ENGINE
ActiveMA46646Aovercomes drawback
Owner:IVAR SPA
Pharmaceutical composition comprising an aromatic heterocyclic amide compound containing bicyclic nitrogen as the active ingredient.
UndeterminedMA41158A
Owner:ASTELLAS PHARMA INC
MEASURING DEVICE, PARTICULARLY FOR THE DETECTION OF DIHYDROGEN IN THE SOIL OF A REGION
ActiveMA56434A
Owner:GDF SUEZ SA
DISTRIBUTION DEVICE COMPRISING A DRIVE MECHANISM INCLUDING CONVERGING RAMPS
UndeterminedMA41779A
Owner:ELI LILLY & CO
METHOD FOR ADAPTING THE CLOSING SPEED OF AT LEAST ONE OPENING OF A MOTOR VEHICLE AND SYSTEM USING SUCH A METHOD
UndeterminedMA49800A
Owner:PSA AUTOMOBILES SA
SYSTEMS AND METHODS FOR ANALYZING INSULIN REGIMEN ADHERENCE DATA
UndeterminedMA45526A
Owner:NOVO NORDISK AS
Pyrazolopyridine derivatives as HPK1 modulators and their uses in cancer treatment
UndeterminedMA46191A
Owner:INCYTE CORP
Formulations containing heparan sulfate for the treatment and prevention of viral infections caused by orthocoronavirids
UndeterminedMA71668A
Owner:ZONA SWISS SA
LOW PRESSURE MULTI-DESCENT CASTING PROCESS AND ALUMINUM ALLOY WHEEL DEVICE
Owner:CITIC DICASTAL CO LTD
BICYCLIC SULFONES AND SULFOXYDES AND ASSOCIATED METHODS OF USE
UndeterminedMA50503A
Owner:F HOFFMANN LA ROCHE & CO AG
ALLOSTERIC EGFR INHIBITORS AND THEIR METHODS OF USE
UndeterminedMA56545A
Owner:DANA FARBER CANCER INSTITUTE INC
COMPOSITIONS FOR THE TREATMENT OF DISORDERS RELATED TO HYPERKERATOSE
UndeterminedMA44737A
Owner:AZURA OPHTHALMICS LTD
ALPHAVIRUS-BASED REPLICONS FOR THE ADMINISTRATION OF BIOTHERAPEUTIC AGENTS
UndeterminedMA53858A
Owner:JANSSEN PHARMACEUTICALS INC
NEW HETEROCYCLIC COMPOUNDS USED AS MONOACYLGLYCEROL LIPASE INHIBITORS
UndeterminedMA53220A
Owner:F HOFFMANN LA ROCHE & CO AG
CANCER TREATMENT METHODS WITH BISOPECIFIC ANTI-CD3XMUC16 AND ANTI-PD-1 ANTIBODIES
UndeterminedMA71708A
Owner:REGENERON PHARMACEUTICALS INC
CYCLIC TETAMER COMPOUNDS SERVING AS PROPROTEIN CONVERTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS
UndeterminedMA54284A
Owner:NOVARTIS AG
PROBATION DETECTION SYSTEM USING INTRABODY COMMUNICATIONS (IBC)
UndeterminedMA49764A
Owner:LOGSENT SAS
TREATMENT OF ABDOMINAL PAIN ASSOCIATED WITH IRRITABLE BOWEL SYNDROME WITH PRE-POST-DIARRHEA
UndeterminedMA56128A
Owner:IRONWOOD PHARMACEUTICALS INC
MOORING DEVICE FOR SURFACE FLOATING INSTALLATIONS, INSTALLATION METHOD AND CORRESPONDING DEVICE CALIBRATION METHOD
UndeterminedMA55707A
Owner:RACING YACHT MANAGEMENT INT LTD